Steve Duffy

The table below is a review of notable updates that occurred in November 2023 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

A 10-year-old boy is referred for evaluation of a white spot on his scalp. Can you make the correct diagnosis?

Etripamil is an investigational, self-administered, intranasal calcium channel blocker designed to be a rapid-response therapy for episodic cardiovascular conditions.

The table below is a review of notable updates that occurred in December 2023 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

The US Food and Drug Administration (FDA) approved a wide range of therapies in 2023, including many new molecular entities and biological products. The information below is organized by the month in which the product received approval.

A 64-year-old woman with stable hypothyroidism presents to the clinic after experiencing sudden hair loss 2 weeks following COVID-19 infection, can you make the correct diagnosis?

From mirrors to improve mental health to talking AI toothbrushes, this year’s show ran the gamut of tech innovation.

Steve Duffy is the digital content editor for MPR, part of the Medical Communications Group of Haymarket Media. He holds a BA in media and communications from Dundalk Institute of Technology (Ireland) and an MA in journalism from Griffith College, Dublin, Ireland.

The table below is a review of notable updates that occurred in June 2024 for investigational products in development (not an inclusive list).

Onyda XR is supplied as an orange-flavored oral suspension containing clonidine hydrochloride 0.1mg per mL in a 120mL bottle.